Ji‐Young Lim

562 total citations
32 papers, 415 citations indexed

About

Ji‐Young Lim is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Ji‐Young Lim has authored 32 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 18 papers in Immunology and 12 papers in Oncology. Recurrent topics in Ji‐Young Lim's work include Hematopoietic Stem Cell Transplantation (16 papers), Multiple Myeloma Research and Treatments (8 papers) and Mesenchymal stem cell research (5 papers). Ji‐Young Lim is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Multiple Myeloma Research and Treatments (8 papers) and Mesenchymal stem cell research (5 papers). Ji‐Young Lim collaborates with scholars based in South Korea, United States and United Kingdom. Ji‐Young Lim's co-authors include Chang‐Ki Min, Sung‐Eun Lee, Gyeongsin Park, Tae‐Woo Kim, Yoo‐Jin Kim, Byung‐Sik Cho, Seok Lee, Seok‐Goo Cho, Hee‐Je Kim and Ki‐Seong Eom and has published in prestigious journals such as Blood, Frontiers in Immunology and Journal of Investigative Dermatology.

In The Last Decade

Ji‐Young Lim

31 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji‐Young Lim South Korea 13 171 161 138 117 83 32 415
Kory J. Engelke United States 10 93 0.5× 106 0.7× 202 1.5× 85 0.7× 55 0.7× 16 476
Hella L. Aberson Netherlands 10 118 0.7× 144 0.9× 234 1.7× 118 1.0× 44 0.5× 15 481
Yosuke Masamoto Japan 10 144 0.8× 125 0.8× 135 1.0× 67 0.6× 64 0.8× 57 444
Maryam Behfar Iran 10 156 0.9× 161 1.0× 141 1.0× 69 0.6× 72 0.9× 68 415
Linlin Xu China 9 75 0.4× 77 0.5× 137 1.0× 74 0.6× 52 0.6× 35 357
Debbie Piktel United States 12 73 0.4× 108 0.7× 156 1.1× 88 0.8× 40 0.5× 23 401
Masakazu Sawanobori Japan 9 80 0.5× 166 1.0× 97 0.7× 46 0.4× 38 0.5× 17 357
Belén López‐Millán Spain 13 102 0.6× 102 0.6× 220 1.6× 166 1.4× 92 1.1× 23 458
Alessandra Penatti Italy 7 226 1.3× 49 0.3× 73 0.5× 49 0.4× 40 0.5× 10 481
MR Halie Netherlands 9 141 0.8× 138 0.9× 95 0.7× 82 0.7× 55 0.7× 17 448

Countries citing papers authored by Ji‐Young Lim

Since Specialization
Citations

This map shows the geographic impact of Ji‐Young Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Young Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Young Lim more than expected).

Fields of papers citing papers by Ji‐Young Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐Young Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Young Lim. The network helps show where Ji‐Young Lim may publish in the future.

Co-authorship network of co-authors of Ji‐Young Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐Young Lim. A scholar is included among the top collaborators of Ji‐Young Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐Young Lim. Ji‐Young Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Seung‐Hyun, Sung‐Soo Park, Ji‐Young Lim, et al.. (2022). Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness. Experimental & Molecular Medicine. 54(11). 1967–1978. 13 indexed citations
2.
Park, Sung‐Soo, Ji‐Young Lim, Jung Yeon Lee, et al.. (2022). Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone. Experimental Hematology. 110. 60–68. 2 indexed citations
3.
Lim, Ji‐Young, Tae‐Woo Kim, Sung‐Soo Park, et al.. (2021). Myeloma-Secreted Galectin-1 Potently Interacts with CD304 on Monocytic Myeloid-Derived Suppressor Cells. Cancer Immunology Research. 9(5). 503–513. 13 indexed citations
4.
5.
Lim, Ji‐Young, et al.. (2021). Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease. Experimental Hematology. 98. 36–46.e2. 12 indexed citations
6.
Lim, Ji‐Young, Tae‐Woo Kim, Sung‐Eun Lee, et al.. (2020). CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model. Stem Cell Research & Therapy. 11(1). 254–254. 9 indexed citations
7.
Lim, Ji‐Young, Kyung-Shin Park, Seok Lee, et al.. (2020). Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells. Experimental Hematology and Oncology. 9(1). 22–22. 12 indexed citations
8.
Lee, Sung‐Eun, Ji‐Young Lim, Tae Woo Kim, et al.. (2019). Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation. Journal for ImmunoTherapy of Cancer. 7(1). 35–35. 17 indexed citations
9.
Jeon, Insu, Byung Seok Kim, Il‐Kyu Kim, et al.. (2019). Monocyte-Derived Dendritic Cells Dictate the Memory Differentiation of CD8+ T Cells During Acute Infection. Frontiers in Immunology. 10. 1887–1887. 34 indexed citations
10.
Lee, Sung‐Eun, Ji‐Young Lim, Tae‐Woo Kim, et al.. (2019). Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 25(10). 1933–1943. 49 indexed citations
11.
Lee, Sung‐Eun, Ji‐Young Lim, Tae‐Woo Kim, et al.. (2018). Circulating CD3+CD4+CD161+Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma. BioMed Research International. 2018. 1–8. 3 indexed citations
12.
Lim, Ji‐Young, Mi-Young Park, Sung‐Eun Lee, et al.. (2018). Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases. Biology of Blood and Marrow Transplantation. 24(12). 2381–2396. 13 indexed citations
13.
Hwang, Han Sung, et al.. (2017). A comparative analysis of maternal and fetal 25-hydroxyvitamin D in pregnant women with and without gestational diabetes mellitus. The Journal of Maternal-Fetal & Neonatal Medicine. 31(20). 2748–2755. 6 indexed citations
14.
Lim, Ji‐Young, et al.. (2017). Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model. Journal of Investigative Dermatology. 137(9). 1895–1904. 34 indexed citations
15.
Lim, Ji‐Young, Young-Kwan Lee, Sung‐Eun Lee, et al.. (2015). Attenuation of Hepatic Graft-versus-host Disease in Allogeneic Recipients of MyD88-deficient Donor Bone Marrow. Immune Network. 15(3). 125–125. 4 indexed citations
16.
Lim, Ji‐Young, et al.. (2014). Inhibition of indoleamine 2,3-dioxygenase by stereoisomers of 1-methyl tryptophan in an experimental graft-versus-tumor model. Experimental Hematology. 42(10). 862–866.e3. 14 indexed citations
17.
Lee, Sung‐Eun, Ji‐Young Lim, Jae‐Ho Yoon, et al.. (2014). CD161+ T Cells as Predictive Markers for Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 21(3). 421–428. 14 indexed citations
18.
Lim, Ji‐Young, Byung‐Sik Cho, Chang‐Ki Min, et al.. (2013). Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease. Immunological Investigations. 43(1). 41–53. 11 indexed citations
19.
Cho, Byung‐Sik, Ji‐Young Lim, Seung‐Ah Yahng, et al.. (2011). Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation. Annals of Hematology. 91(3). 439–448. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kory J. Engelke Breakdown of academic impact, for papers by Hella L. Aberson Breakdown of academic impact, for papers by Yosuke Masamoto Breakdown of academic impact, for papers by Maryam Behfar Breakdown of academic impact, for papers by Linlin Xu Breakdown of academic impact, for papers by Debbie Piktel Breakdown of academic impact, for papers by Masakazu Sawanobori Breakdown of academic impact, for papers by Belén López‐Millán Breakdown of academic impact, for papers by Alessandra Penatti Breakdown of academic impact, for papers by MR Halie
Rankless by CCL
2026